首页 | 本学科首页   官方微博 | 高级检索  
检索        

从我院卵巢癌收治情况看卵巢癌诊治现状
引用本文:张海燕,令狐华,徐冬梅.从我院卵巢癌收治情况看卵巢癌诊治现状[J].高校保健医学研究与实践,2009,6(2):35-38.
作者姓名:张海燕  令狐华  徐冬梅
作者单位:张海燕,ZHANG Hai-yan(重庆医科大学附属第一医院,妇产科,重庆,400016;浙江省温岭市第一人民医院,妇产科,浙江,温岭,317500);令狐华,LING hu Hua(重庆医科大学附属第一医院,妇产科,重庆,400016);徐冬梅,XU Dong-mei(重庆市妇幼保健院,妇产科,重庆,400010)  
摘    要:目的探讨近10年来本地区卵巢癌诊断和治疗现况。方法收集1998年1月-2008年1月我院所有拟诊为卵巢癌患者的基本信息和治疗情况,并作统计分析。结果我院收治的471例卵巢癌患者中,433例接受了手术治疗并获得明确病理组织学分型,71.62%就诊时已是Ⅲ~Ⅳ期,324例行初次手术。436例接受了化疗,出现明确化疗副反应的有314人次。146例患者复发,在随访到的患者中,3年生存率和5年生存率只有29.14%和9.27%。结论近10年来卵巢癌就诊人数明显增加,但有限的治疗手段使得晚期癌生存状况仍不容乐观。

关 键 词:卵巢癌  诊治  复发

Treatment of Epithelial Ovarian Carcinoma in Our Hospital During the Past 10 Years
ZHANG Hai-yan,LING hu Hua,XU Dong-mei.Treatment of Epithelial Ovarian Carcinoma in Our Hospital During the Past 10 Years[J].Health Medicine Research and Practice in Higher Institutions,2009,6(2):35-38.
Authors:ZHANG Hai-yan  LING hu Hua  XU Dong-mei
Institution:1. Department of gynecology and obstetrics, The First Affiliated Hospital of Chongqing Medical University ,Chongqing 400016,China; 2. Department of gynecology and obstetrics, The First People's Hospital of Wenling ,Wenling Zhejiang 317500, China; 3. Department of gynecology and obstetrics, Chongqing Maternal and Child Health hospital, Chongqing 400010, China)
Abstract:Objective To review the status of diagnosis and treatment in epithelial ovarian carcinoma in our hospital in recent 10 years. Method A retrospective study for 452 patients with epithelial ovarian carcinoma in The First Affiliated Hospital of Chongqing Medical University between January 1998 and January 2008 was performed. Their age, histologic type,FIGO stage, tumor grade, measures of management and laboratory tests were collected and analyzed. Results A total of 452 cases were recorded in 2 121 case files, and 433 patients received surgical intervention and got identified histology. 71.62% of them were already at stage Ⅲ-Ⅳ on seeing a doctor. 324 cases underwent surgery for the first time. 436 patients received chemotherapy, and obvious side effects were reported in 314 patients. Recurrence occurred in 146 patients, and 3-year survival rate and 5-year survival rate was 29.14% and 9.27%, respectively. Conclusions The incidence of epithelial ovarian carcinoma increased greatly in recent 10 years. However, the survival for advanced diseases remains quite poor because of limited means of management.
Keywords:Ovarian carcinoma  Diagnosis and treatment  Recurrence
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号